Table 3 Results of CMAP analysis.
Rank | Cmap name | Enrichment | p | Therapeutic Use | |
|---|---|---|---|---|---|
Four mixtures | 1 | phenoxybenzamine | 0.981 | 0 | Antihypertensive Agents, Vasodilator Agents |
2 | lanatoside C | 0.981 | 0 | Cardiovascular Agents | |
3 | digitoxigenin | 0.978 | 0 | Cardiotonic Agents | |
5 | digoxigenin | 0.967 | 0 | Cardiotonic Agents | |
7 | ouabain | 0.962 | 0 | Cardiotonic Agents | |
8 | digoxin | 0.959 | 0 | Anti-Arrhythmia Agents, Cardiotonic Agents | |
28 | proscillaridin | 0.968 | 0.00004 | Cardiotonic Agents | |
60 | beta-escin | 0.663 | 0.00427 | Cardiovascular Agents | |
62 | bepridil | 0.778 | 0.00464 | Anti-Arrhythmia Agents, Vasodilator Agents | |
73 | strophanthidin | 0.738 | 0.00927 | Cardiovascular Agents | |
75 | tetrandrine | 0.733 | 0.00989 | Calcium Channel Blockers | |
Tanshinone IIA | 15 | phenoxybenzamine | 0.85 | 0.00072 | Antihypertensive Agents, Vasodilator Agents |
17 | lanatoside C | 0.738 | 0.00085 | Cardiovascular Agents | |
23 | beta-escin | 0.711 | 0.00167 | Cardiovascular Agents | |
44 | ouabain | 0.733 | 0.00989 | Cardiotonic Agents | |
Salvianic acid A sodium | 16 | timolol | 0.761 | 0.00621 | Anti-Arrhythmia Agents |
17 | labetalol | 0.761 | 0.00623 | Antihypertensive Agents | |
18 | fenofibrate | 0.847 | 0.00693 | Hypolipidemic Agents | |
20 | propranolol | 0.749 | 0.0076 | Anti-Arrhythmia Agents, Antihypertensive Agents, Vasodilator Agents | |
protocatechuic aldehyde | 12 | pronetalol | 0.771 | 0.00539 | Antihypertensive Agents |
23 | guanabenz | 0.676 | 0.00927 | Antihypertensive Agents | |
Salvianolic acid B | 15 | benfluorex | 0.796 | 0.00338 | Hypolipidemic Agents |
